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Mutations in HSPB1 and HSPB8, members of the
small heat shock protein family, have recently been
shown to cause some distal motor neuropathies.
Their function in motor neurones is now under
scrutiny.
Members of the small heat shock protein (sHSP) family
are protein chaperones [1] that are important in the
stress response of cells, particularly neurones [2]. These
chaperones protect against a variety of stresses, from
heat to oxidative stress and usually have anti-apoptotic
activity [2,3]. One of the family members, HSPB1, can
also suppress the toxic effects of the polyglutamine
protein, huntingtin, and decrease the levels of reactive
oxygen species produced as part of the response to this
toxic protein [3]. Coincidentally, sHSPs are often upreg-
ulated in neurodegenerative diseases (see [4] and refer-
ences therein) and also in motor neurone cell injury [2].
The protective activity of these proteins can be cell-type
dependent because HSPB1 protects against apoptotic
stimuli in neurones [2,3], but not cardiomyocytes [5].
Some sHSPs, like HSPB8 are even pro-apoptotic [6],
despite being upregulated in disease [7]. Now, two
recent papers in Nature Genetics [8,9] have identified a
genetic link between HSPB1 and HSPB8 and the distal
neuropathies, Charcot Marie Tooth Disease (CMT) and
Hereditary Distal Motor Neuropathy (HMN), exposing an
important gap in our knowledge, namely the function of
these specific sHSPs in motor neurones.
The sHSPs form a large protein family [1] comprising
proteins typified by a highly conserved sequence of
~90 amino acid residues in the carboxy-terminal
region, called the α-crystallin domain, and by their rel-
atively low molecular weight (~20–25 kDa). Of the 10
different human sHSPs that are currently known [1],
some, like HSPB1 [8], are widely expressed, whereas
others, such as HSPB8 [9], are more restricted in their
expression. Both HSPB1 and HSPB8 are found in the
nervous system, where they are expressed in different
neuronal cell types [8,9], although both are expressed
in motor neurones. HSPB8, on the other hand, is highly
expressed in heart and liver with reduced levels in
skeletal muscle, lung, kidney, testis and brain [9].
These observations of the sHSP expression patterns
pose the question: why are motor neurones the spe-
cific target of the HSPB1 and HSPB8 mutations? 
At least part of the answer lies in the diversity of the
interactions and functions of sHSPs, which explains
why there is not necessarily a direct correlation
between sHSP levels and the tissue affected by the
sHSP mutations. HSPB1 and HSPB8 operate in associ-
ation with other sHSPs [7], as well as with other chap-
erones, such as those of the HSP70 class. HSPB8 also
has kinase activity (see [7] and references therein) and
potentially has a direct link to the Akt/PKB kinase
pathway [10]. This complexity makes identifying a
unique function for these proteins quite a difficult task,
especially when one considers that potential targets
can include individual proteins as well as macromolec-
ular structures such as the cytoskeleton [11].
One important function of HSPB1 is to interact with
intermediate filaments and maintain the integrity of
intermediate filament networks in cells [12,13]. In this
respect, HSPB1 is very much like HSPB5, another
sHSP that has been linked to a protein-inclusion-based
disease involving the cytoskeleton, namely desmin-
related myopathy. The aggregation of intermediate fila-
ments along with their associated sHSPs, HSPB5 and
HSPB1, is a prominent histopathological feature of this
disease. The R120G mutation in HSPB5 associated with
desmin-related myopathy induces intermediate filament
aggregation [13]. Interestingly, neurofilament aggrega-
tion in the cell body upon expression of mutant sHSP1
[8] and neurofilament mutations are also features of
motor neurone disease [14]. Transfection of some of
the HSPB1 mutants leads to the collapse of neurofila-
ment networks and so the link to neurofilaments is
more than just coincidental. Indeed the K141E mutation
in HSPB8 is equivalent to the R120G mutation in
HSPB5 [9] and, although at present HSPB8 has not
been shown to interact directly with intermediate fila-
ments, it is possible that it does associate with these fil-
aments via HSPB1 [7]. The fact that mutations in
neurofilament proteins [14] are associated with the
CMT2 neuropathies and amyotrophic lateral sclerosis
provides compelling genetic evidence of a key interac-
tion between these sHSP chaperones and the interme-
diate filament cytoskeleton that cannot be ignored.
The neurofilament cytoskeleton is highly dependent
upon the efficient transport of filament subunits [15].
These transport processes might also call upon another
cytoskeletal role of HSPB1, namely the modulation of
actin-based networks [12]. To us it would seem highly
likely that the reported HSPB1 mutations will either
directly or indirectly disrupt cytoskeletal function and
affect neurofilament transport. The reported disruption
of the neurofilament networks in cells transfected with
HSPB1 mutants is good supporting evidence [8]. One
of the downstream consequences of such a disruption
could then be mitochondrial dysfunction [14,16], which
will propagate apoptotic pathways and of course this
would be exacerbated by the loss of sHSP activity,
seeing as most are known inhibitors of apoptosis, with
the exception of HSPB8 which can be proapoptotic [6].
To complete our unravelling of the present conundra,
it is worth noting that the most recent literature now
links protein inclusion formation to ageing via sHSPs in
Caenorhabditis elegans ([17] and references therein).
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Given the fact that patients with CMT neuropathies clin-
ically present only later in life [8], the aggregates may
have indirect and delayed effects rather than immedi-
ate consequences for normal tissue function. The sHSP
mutations may have invoked a chronic rather than an
acute process with accumulated damage perhaps as a
result of oxidative stress in these motor neurones that
eventually culminates in their early death. In proliferat-
ing cells, this type of stress can induce premature
ageing, but the differentiated phenotype of the neurone
does not allow such an outcome and the steady loss of
motor neurones ensues instead. It is worth mentioning
at this point that mutations in A-type lamins, encoded
by a progeria-linked gene [18], also cause CMT2 [19].
At a time when sHSPs have been linked to extended
lifespan [17], hyperproliferation via p53 stability [20] and
the inhibition of apoptosis [2], it is clear that we need to
consider carefully the full potential of sHSP function in
neurones as we unravel the pathogenic process in
these tissues (Figure 1). 
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Figure 1. The relationships between
sHSPs, elements of the cytoskeleton and
various cellular processes. 
So far, sHSP mutations are known to affect
intermediate filament (IF) function, causing
the aggregation of these filaments into cyto-
plasmic inclusions typical of the peripheral
neuropathies recently described [8,9].
sHSPS also interact with microfilaments
(MFs) and microtubules (MTs), but disruption
of this interaction has not yet been linked to
any human diseases. Loss of sHSP function
contributes to increased oxidative damage
in the cell and also to increased proteosomal
load. Mutations in intermediate filament pro-
teins, and possibly also in sHSPs, can cause
mitochondrial and nuclear dysfunction.
Oxidative damage, proteosomal inhibition,
mitochondrial and nuclear dysfunction can
all trigger apoptosis, which in motor neu-
rones induces the described neuropathies
as a result of the HSPB1 and HSPB8 muta-
tions. Chronic exposure of cells to oxidative
stress also induces premature ageing by
accelerating the onset of senescence. 
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